Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of ARA290 for diabetic neuropathic pain
NL-OMON34461Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cibinetide in diabetic neuropathy, Neuralgia and small fiber neuropathy (SFN), sponsored by Leiden University Medical Center. Primary endpoint: Pain relief. Started Dec 2010; status: active, not recruiting.
02
Drugs
cibinetide
03
Conditions
diabetic neuropathyNeuralgiasmall fiber neuropathy (SFN)
Beyond the preview
Go deeper on NL-OMON34461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34461.